Cargando…
Integrin α6Bβ4 inhibits colon cancer cell proliferation and c-Myc activity
BACKGROUND: Integrins are known to be important contributors to cancer progression. We have previously shown that the integrin β4 subunit is up-regulated in primary colon cancer. Its partner, the integrin α6 subunit, exists as two different mRNA splice variants, α6A and α6B, that differ in their cyt...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715428/ https://www.ncbi.nlm.nih.gov/pubmed/19586553 http://dx.doi.org/10.1186/1471-2407-9-223 |
_version_ | 1782169778755993600 |
---|---|
author | Dydensborg, Anders Bondo Teller, Inga C Groulx, Jean-François Basora, Nuria Paré, Fréderic Herring, Elizabeth Gauthier, Rémy Jean, Dominique Beaulieu, Jean-François |
author_facet | Dydensborg, Anders Bondo Teller, Inga C Groulx, Jean-François Basora, Nuria Paré, Fréderic Herring, Elizabeth Gauthier, Rémy Jean, Dominique Beaulieu, Jean-François |
author_sort | Dydensborg, Anders Bondo |
collection | PubMed |
description | BACKGROUND: Integrins are known to be important contributors to cancer progression. We have previously shown that the integrin β4 subunit is up-regulated in primary colon cancer. Its partner, the integrin α6 subunit, exists as two different mRNA splice variants, α6A and α6B, that differ in their cytoplasmic domains but evidence for distinct biological functions of these α6 splice variants is still lacking. METHODS: In this work, we first analyzed the expression of integrin α6A and α6B at the protein and transcript levels in normal human colonic cells as well as colorectal adenocarcinoma cells from both primary tumors and established cell lines. Then, using forced expression experiments, we investigated the effect of α6A and α6B on the regulation of cell proliferation in a colon cancer cell line. RESULTS: Using variant-specific antibodies, we observed that α6A and α6B are differentially expressed both within the normal adult colonic epithelium and between normal and diseased colonic tissues. Proliferative cells located in the lower half of the glands were found to predominantly express α6A, while the differentiated and quiescent colonocytes in the upper half of the glands and surface epithelium expressed α6B. A relative decrease of α6B expression was also identified in primary colon tumors and adenocarcinoma cell lines suggesting that the α6A/α6B ratios may be linked to the proliferative status of colonic cells. Additional studies in colon cancer cells showed that experimentally restoring the α6A/α6B balance in favor of α6B caused a decrease in cellular S-phase entry and repressed the activity of c-Myc. CONCLUSION: The findings that the α6Bβ4 integrin is expressed in quiescent normal colonic cells and is significantly down-regulated in colon cancer cells relative to its α6Aβ4 counterpart are consistent with the anti-proliferative influence and inhibitory effect on c-Myc activity identified for this α6Bβ4 integrin. Taken together, these findings point out the importance of integrin variant expression in colon cancer cell biology. |
format | Text |
id | pubmed-2715428 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27154282009-07-25 Integrin α6Bβ4 inhibits colon cancer cell proliferation and c-Myc activity Dydensborg, Anders Bondo Teller, Inga C Groulx, Jean-François Basora, Nuria Paré, Fréderic Herring, Elizabeth Gauthier, Rémy Jean, Dominique Beaulieu, Jean-François BMC Cancer Research Article BACKGROUND: Integrins are known to be important contributors to cancer progression. We have previously shown that the integrin β4 subunit is up-regulated in primary colon cancer. Its partner, the integrin α6 subunit, exists as two different mRNA splice variants, α6A and α6B, that differ in their cytoplasmic domains but evidence for distinct biological functions of these α6 splice variants is still lacking. METHODS: In this work, we first analyzed the expression of integrin α6A and α6B at the protein and transcript levels in normal human colonic cells as well as colorectal adenocarcinoma cells from both primary tumors and established cell lines. Then, using forced expression experiments, we investigated the effect of α6A and α6B on the regulation of cell proliferation in a colon cancer cell line. RESULTS: Using variant-specific antibodies, we observed that α6A and α6B are differentially expressed both within the normal adult colonic epithelium and between normal and diseased colonic tissues. Proliferative cells located in the lower half of the glands were found to predominantly express α6A, while the differentiated and quiescent colonocytes in the upper half of the glands and surface epithelium expressed α6B. A relative decrease of α6B expression was also identified in primary colon tumors and adenocarcinoma cell lines suggesting that the α6A/α6B ratios may be linked to the proliferative status of colonic cells. Additional studies in colon cancer cells showed that experimentally restoring the α6A/α6B balance in favor of α6B caused a decrease in cellular S-phase entry and repressed the activity of c-Myc. CONCLUSION: The findings that the α6Bβ4 integrin is expressed in quiescent normal colonic cells and is significantly down-regulated in colon cancer cells relative to its α6Aβ4 counterpart are consistent with the anti-proliferative influence and inhibitory effect on c-Myc activity identified for this α6Bβ4 integrin. Taken together, these findings point out the importance of integrin variant expression in colon cancer cell biology. BioMed Central 2009-07-09 /pmc/articles/PMC2715428/ /pubmed/19586553 http://dx.doi.org/10.1186/1471-2407-9-223 Text en Copyright ©2009 Dydensborg et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Dydensborg, Anders Bondo Teller, Inga C Groulx, Jean-François Basora, Nuria Paré, Fréderic Herring, Elizabeth Gauthier, Rémy Jean, Dominique Beaulieu, Jean-François Integrin α6Bβ4 inhibits colon cancer cell proliferation and c-Myc activity |
title | Integrin α6Bβ4 inhibits colon cancer cell proliferation and c-Myc activity |
title_full | Integrin α6Bβ4 inhibits colon cancer cell proliferation and c-Myc activity |
title_fullStr | Integrin α6Bβ4 inhibits colon cancer cell proliferation and c-Myc activity |
title_full_unstemmed | Integrin α6Bβ4 inhibits colon cancer cell proliferation and c-Myc activity |
title_short | Integrin α6Bβ4 inhibits colon cancer cell proliferation and c-Myc activity |
title_sort | integrin α6bβ4 inhibits colon cancer cell proliferation and c-myc activity |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715428/ https://www.ncbi.nlm.nih.gov/pubmed/19586553 http://dx.doi.org/10.1186/1471-2407-9-223 |
work_keys_str_mv | AT dydensborgandersbondo integrina6bb4inhibitscoloncancercellproliferationandcmycactivity AT telleringac integrina6bb4inhibitscoloncancercellproliferationandcmycactivity AT groulxjeanfrancois integrina6bb4inhibitscoloncancercellproliferationandcmycactivity AT basoranuria integrina6bb4inhibitscoloncancercellproliferationandcmycactivity AT parefrederic integrina6bb4inhibitscoloncancercellproliferationandcmycactivity AT herringelizabeth integrina6bb4inhibitscoloncancercellproliferationandcmycactivity AT gauthierremy integrina6bb4inhibitscoloncancercellproliferationandcmycactivity AT jeandominique integrina6bb4inhibitscoloncancercellproliferationandcmycactivity AT beaulieujeanfrancois integrina6bb4inhibitscoloncancercellproliferationandcmycactivity |